Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.7.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.3.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CQ.1.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EC.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.52SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XMSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.48SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
JQ.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.10.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BL.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.23SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BL.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BE.7SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.9.5SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.6.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.34SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.12SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.7.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CE.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EA.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.22SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DH.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XGSWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BF.6SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.3.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.7SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.2.8NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.7.11NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CE.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EA.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.22NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
DH.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XGNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.6NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.5.3.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.5.2.7NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XMNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.1.1.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.70NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-17480.9Singapore
BA.2.63NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.4.1.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BQ.1.8.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
EC.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BM.1.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XLNYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BD.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
AY.87 (Delta)NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.23.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used